BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 3391520)

  • 1. The epidemiology of gallstone disease in Rome, Italy. Part II. Factors associated with the disease. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO).
    Hepatology; 1988; 8(4):907-13. PubMed ID: 3391520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis.
    Attili AF; Capocaccia R; Carulli N; Festi D; Roda E; Barbara L; Capocaccia L; Menotti A; Okolicsanyi L; Ricci G; Lalloni L; Mariotti S; Sama C; Scafato E
    Hepatology; 1997 Oct; 26(4):809-18. PubMed ID: 9328297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of gallstone disease in an Italian adult female population. Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO).
    Am J Epidemiol; 1984 May; 119(5):796-805. PubMed ID: 6720676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of gallstone disease in Rome, Italy. Part I. Prevalence data in men. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO).
    Hepatology; 1988; 8(4):904-6. PubMed ID: 3391519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year incidence and natural history of gallstone disease in a rural population of women in central Italy. The Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO).
    Angelico F; Del Ben M; Barbato A; Conti R; Urbinati G
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):249-54. PubMed ID: 9646217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallstone prevalence in Christchurch: risk factors and clinical significance.
    Chapman BA; Frampton CM; Wilson IR; Chisholm RJ; Allan RB; Burt MJ
    N Z Med J; 2000 Feb; 113(1104):46-8. PubMed ID: 10777222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
    Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
    J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
    Undén AL; Elofsson S; Brismar K
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for symptomatic gallstones in patients with liver cirrhosis: a case-control study.
    Acalovschi M; Blendea D; Feier C; Letia AI; Ratiu N; Dumitrascu DL; Veres A
    Am J Gastroenterol; 2003 Aug; 98(8):1856-60. PubMed ID: 12907344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence.
    Völzke H; Baumeister SE; Alte D; Hoffmann W; Schwahn C; Simon P; John U; Lerch MM
    Digestion; 2005; 71(2):97-105. PubMed ID: 15775677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholelithiasis in patients with chronic active liver disease: evaluation of risk factors.
    Castellano L; De Sio I; Silvestrino F; Marmo R; Del Vecchio Blanco C
    Ital J Gastroenterol; 1995; 27(8):425-9. PubMed ID: 8775468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal antiinflammatory drug use and gallstone disease prevalence: a case-control study.
    Pazzi P; Scagliarini R; Sighinolfi D; Govoni M; La Corte R; Gullini S
    Am J Gastroenterol; 1998 Sep; 93(9):1420-4. PubMed ID: 9732918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical correlates of gallstone composition: distinguishing pigment from cholesterol stones.
    Diehl AK; Schwesinger WH; Holleman DR; Chapman JB; Kurtin WE
    Am J Gastroenterol; 1995 Jun; 90(6):967-72. PubMed ID: 7771432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence rates of gallstone disease in Italy. The Chianciano population study.
    Loria P; Dilengite MA; Bozzoli M; Carubbi F; Messora R; Sassatelli R; Bertolotti M; Tampieri A; Tartoni PL; Cassinadri M
    Eur J Epidemiol; 1994 Apr; 10(2):143-50. PubMed ID: 7813691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Known risk factors do not explain disparities in gallstone prevalence between Denmark and northeast Germany.
    Friedrich N; Völzke H; Hampe J; Lerch MM; Jørgensen T
    Am J Gastroenterol; 2009 Jan; 104(1):89-95. PubMed ID: 19098855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallstone disease and related risk factors in a large cohort of diabetic patients.
    Pagliarulo M; Fornari F; Fraquelli M; Zoli M; Giangregorio F; Grigolon A; Peracchi M; Conte D
    Dig Liver Dis; 2004 Feb; 36(2):130-4. PubMed ID: 15002821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and bile lipids in young women with radiolucent gallstones.
    Cavallini A; Messa C; Mangini V; Argese V; Misciagna G; Giorgio I
    Am J Gastroenterol; 1987 Dec; 82(12):1279-82. PubMed ID: 3687905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of multiple coronary risk factors in Punjabi Bhatia community: Jaipur Heart Watch-3.
    Gupta R; Sarna M; Thanvi J; Rastogi P; Kaul V; Gupta VP
    Indian Heart J; 2004; 56(6):646-52. PubMed ID: 15751521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.
    McNicoll S; Latour Y; Rondeau C; Bouthillier D; Davignon J; Genest J
    Can J Cardiol; 1995 Feb; 11(2):109-16. PubMed ID: 7866933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallstones, gallbladder disease, and pancreatitis: cross-sectional and 2-year data from the Swedish Obese Subjects (SOS) and SOS reference studies.
    Torgerson JS; Lindroos AK; Näslund I; Peltonen M
    Am J Gastroenterol; 2003 May; 98(5):1032-41. PubMed ID: 12809825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.